NASDAQ: ONCO · Life Sciences · 6 alerts · CIK 1782107
Share price
$2.91Close, Nov 16
Market cap
$11.5M
Shares outstanding
3.95MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Onconetix, Inc. filings on SEC EDGAR ↗
Onconetix entered into a first amendment to its existing share exchange agreement with Realbotix Corp. to acquire Realbotix, LLC. The amendment modifies the ownership structure such that the seller will own 95% of the buyer if net cash is less than $12.5 million and extends the deal's outside closing date to March 31, 2027.
Onconetix provided a $5.0 million strategic bridge financing facility to Realbotix, LLC, the target of its previously announced pending acquisition. The facility is non-interest bearing and will be automatically cancelled and discharged upon the closing of the all-stock merger. This update supports the working capital needs of Realbotix as the parties work toward completing the transaction.